An active ingredient is the substance in a pharmaceutical, biologic, or other product that is responsible for producing the intended therapeutic or physiological effect. In translation work, the term appears in drug labels, summary of product characteristics, analytical documents, and regulatory submissions where accurate identification of the molecule is critical for safety and efficacy assessment, as well as for consistency across documents.
In localization, active ingredient appears in summary of product characteristics, patient information leaflets, labeling, certificates of analysis, clinical trial documents, and packaging artwork. Translators must match common names to official pharmacopeial names and keep terminology consistent across both regulatory submissions and patient-facing materials. It may also occur in pharmacovigilance reports and product quality reviews.
A frequent mistake is translating an active ingredient's common name literally instead of using the established pharmacopeial or international nonproprietary name. Inconsistent naming across summary documents, labels, and patient materials can confuse regulators, create safety risks, and trigger queries. This is especially dangerous when multiple salts or derivatives share similar names.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →